Intra-Cellular Therapies, Inc. Skyrocketed

Intra-Cellular Therapies, Inc. (ITCI:NASDAQ) soared at $31.86, representing a gain of 72.9%. On Tue 08 Sep 20, ITCI:NASDAQ hit a New 2-Week Intraday High of $18.93. The stock appeared on our News Catalysts scanner on Wed 09 Sep 20 at 05:15 PM in the 'PUBLIC OFFERING' category. From Tue 25 Aug 20, the stock recorded 55.56% Up Days and 40.00% Green Days

The stock spiked on Tue 23 Jun 20 at $27.65 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About Intra-Cellular Therapies, Inc. (ITCI:NASDAQ)

Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.